126 related articles for article (PubMed ID: 26347476)
1. Ultrasonography screening for hepatocellular carcinoma in Japanese patients with diabetes mellitus.
Hiraoka A; Ochi M; Matsuda R; Aibiki T; Okudaira T; Kawamura T; Yamago H; Nakahara H; Suga Y; Azemoto N; Miyata H; Miyamoto Y; Ninomiya T; Hirooka M; Abe M; Matsuura B; Hiasa Y; Michitaka K
J Diabetes; 2016 Sep; 8(5):640-6. PubMed ID: 26347476
[TBL] [Abstract][Full Text] [Related]
2. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial.
Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Han K; Nam CM; Park SH; Lee KH
BMC Cancer; 2017 Apr; 17(1):279. PubMed ID: 28420329
[TBL] [Abstract][Full Text] [Related]
4. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan.
Tateishi R; Matsumura T; Okanoue T; Shima T; Uchino K; Fujiwara N; Senokuchi T; Kon K; Sasako T; Taniai M; Kawaguchi T; Inoue H; Watada H; Kubota N; Shimano H; Kaneko S; Hashimoto E; Watanabe S; Shiota G; Ueki K; Kashiwabara K; Matsuyama Y; Tanaka H; Kasuga M; Araki E; Koike K;
J Gastroenterol; 2021 Mar; 56(3):261-273. PubMed ID: 33427937
[TBL] [Abstract][Full Text] [Related]
6. Proposed a simple score for recommendation of scheduled ultrasonography surveillance for hepatocellular carcinoma after Direct Acting Antivirals: multicenter analysis.
Hiraoka A; Kumada T; Ogawa C; Kariyama K; Morita M; Nouso K; Toyoda H; Tada T; Ochi M; Murakami T; Izumoto H; Ueki H; Kitahata S; Aibiki T; Okudaira T; Yamago H; Iwasaki R; Tomida H; Miyamoto Y; Mori K; Miyata H; Tsubouchi E; Kishida M; Ninomiya T; Michitaka K
J Gastroenterol Hepatol; 2019 Feb; 34(2):436-441. PubMed ID: 29996177
[TBL] [Abstract][Full Text] [Related]
7. Stratification of hepatocellular carcinoma risk through modified FIB-4 index in chronic hepatitis B patients on entecavir therapy.
Wang HW; Lai HC; Hu TH; Su WP; Lu SN; Lin CH; Hung CH; Chuang PH; Wang JH; Lee MH; Chen CH; Peng CY
J Gastroenterol Hepatol; 2019 Feb; 34(2):442-449. PubMed ID: 29968933
[TBL] [Abstract][Full Text] [Related]
8. Surveillance for Hepatocellular Carcinoma: Does the Place Where Ultrasound Is Performed Impact Its Effectiveness?
Piñero F; Rubinstein F; Marciano S; Fernández N; Silva J; Zambelo Y; Anders M; Zerega A; Ridruejo E; Miguez C; Ameigeiras B; D'Amico C; Gaite L; Bermúdez C; Rosales C; Romero G; McCormack L; Reggiardo V; Colombato L; Gadano A; Silva M
Dig Dis Sci; 2019 Mar; 64(3):718-728. PubMed ID: 30511199
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound surveillance for hepatocellular carcinoma of at-risk patients in Ramathibodi Hospital.
Prapruttam D; Suksai J; Kitiyakara T; Phongkitkarun S
J Med Assoc Thai; 2014 Nov; 97(11):1199-208. PubMed ID: 25675686
[TBL] [Abstract][Full Text] [Related]
10. Predictive Value of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Early Recurrence of Hepatocellular Carcinoma after Surgical Resection.
Wang Y; Liao J; Qi W; Xie L; Li Y
Ultrasound Med Biol; 2016 May; 42(5):1042-8. PubMed ID: 26803390
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C-positive Black patients develop hepatocellular carcinoma at earlier stages of liver disease and present with a more aggressive phenotype.
Shaltiel T; Zheng S; Siderides C; Gleeson EM; Carr J; Pletcher ER; Cohen NA; Golas BJ; Magge DR; Labow DM; Branch AD; Sarpel U
Cancer; 2021 May; 127(9):1395-1406. PubMed ID: 33629759
[TBL] [Abstract][Full Text] [Related]
12. Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis.
Farhang Zangneh H; Wong WWL; Sander B; Bell CM; Mumtaz K; Kowgier M; van der Meer AJ; Cleary SP; Janssen HLA; Chan KKW; Feld JJ
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1840-1849.e16. PubMed ID: 30580095
[TBL] [Abstract][Full Text] [Related]
13. MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma.
Kim SY; An J; Lim YS; Han S; Lee JY; Byun JH; Won HJ; Lee SJ; Lee HC; Lee YS
JAMA Oncol; 2017 Apr; 3(4):456-463. PubMed ID: 27657493
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced US with Perfluorobutane for Hepatocellular Carcinoma Surveillance: A Multicenter Diagnostic Trial (SCAN).
Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Lee SS; Han K; Nam CM; Park SH; Lee KH
Radiology; 2019 Sep; 292(3):638-646. PubMed ID: 31287387
[TBL] [Abstract][Full Text] [Related]
15. Rate of Nonsurveillance and Advanced Hepatocellular Carcinoma at Diagnosis in Chronic Liver Disease.
Huang Y; Wallace MC; Adams LA; MacQuillan G; Garas G; Ferguson J; Samuelson S; Tibballs J; Jeffrey GP
J Clin Gastroenterol; 2018 Jul; 52(6):551-556. PubMed ID: 28858944
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
Worland T; Harrison B; Delmenico L; Dowling D
J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
[TBL] [Abstract][Full Text] [Related]
17. [Staging of hepatocellular carcinoma. Comparison of ultrasonography, computerized tomography, magnetic resonance, digital angiography, and computerized tomography with lipiodol].
Bartolozzi C; Lencioni R; Caramella D; Gibilisco G; Cioni R; Vignali C
Radiol Med; 1994 Oct; 88(4):429-36. PubMed ID: 7997616
[TBL] [Abstract][Full Text] [Related]
18. Validation of US Liver Imaging Reporting and Data System Version 2017 in Patients at High Risk for Hepatocellular Carcinoma.
Son JH; Choi SH; Kim SY; Jang HY; Byun JH; Won HJ; Lee SJ; Lim YS
Radiology; 2019 Aug; 292(2):390-397. PubMed ID: 31210614
[TBL] [Abstract][Full Text] [Related]
19. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
Takizawa K; Numata K; Morimoto M; Kondo M; Nozaki A; Moriya S; Ishii T; Oshima T; Fukuda H; Okada M; Takebayashi S; Maeda S; Tanaka K
Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188
[TBL] [Abstract][Full Text] [Related]
20. Surveillance for early diagnosis of hepatocellular carcinoma: how best to do it?
Giannini EG; Cucchetti A; Erroi V; Garuti F; Odaldi F; Trevisani F
World J Gastroenterol; 2013 Dec; 19(47):8808-21. PubMed ID: 24379604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
